Johnson & Johnson Dealt $72 Million Courtroom Loss in Talc-Ovarian Cancer Case
Johnson & Johnson has suffered a major courtroom defeat in the first in a wave of lawsuits claiming that talc products marketed by the company for feminine hygiene use caused ovarian cancer.